ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
60 994,02
0,32%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Edge Therapeutics, Inc. (EDGE)

  7. Edge Therapeutics, Inc. (EDGE) Actualités

EDGE

EDGE THERAPEUTICS, INC. (EDGE)

Edge Therapeutics, Inc.
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EDGE
DateHeureSourceTitreSymboleSociété
18/03/201923h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EDGEEdge Therapeutics, Inc.
18/03/201912h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EDGEEdge Therapeutics, Inc.
04/03/201923h30Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EDGEEdge Therapeutics, Inc.
22/02/201923h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201922h21Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EDGEEdge Therapeutics, Inc.
21/02/201912h15GlobeNewswire Inc.Edge Therapeutics Announces Full Year 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
15/02/201920h35Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:EDGEEdge Therapeutics, Inc.
15/02/201912h09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EDGEEdge Therapeutics, Inc.
13/02/201917h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EDGEEdge Therapeutics, Inc.
25/01/201923h31Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:EDGEEdge Therapeutics, Inc.
03/01/201914h10Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:EDGEEdge Therapeutics, Inc.
21/12/201812h05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:EDGEEdge Therapeutics, Inc.
30/11/201815h39GlobeNewswire Inc.Edison issues update on NetScientific (NSCI)NASDAQ:EDGEEdge Therapeutics, Inc.
26/11/201812h30GlobeNewswire Inc.Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy CompanyNASDAQ:EDGEEdge Therapeutics, Inc.
01/11/201812h15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EDGEEdge Therapeutics, Inc.
01/11/201811h00GlobeNewswire Inc.Edge Therapeutics Reports Third Quarter 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
01/08/201812h00GlobeNewswire Inc.Edge Therapeutics Reports Second Quarter 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
27/06/201822h30GlobeNewswire Inc.Edge Therapeutics Announces Updated Results from Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid HemorrhageNASDAQ:EDGEEdge Therapeutics, Inc.
20/06/201822h47Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:EDGEEdge Therapeutics, Inc.
11/06/201822h03Business WireDEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. &...NASDAQ:EDGEEdge Therapeutics, Inc.
06/06/201818h47Business WireSHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Edge Therapeutics, Inc. ...NASDAQ:EDGEEdge Therapeutics, Inc.
02/05/201815h33GlobeNewswire Inc.Edge Therapeutics Reports First Quarter 2018 Financial ResultsNASDAQ:EDGEEdge Therapeutics, Inc.
02/05/201815h33GlobeNewswire Inc.Edge Therapeutics Announces Review of Strategic AlternativesNASDAQ:EDGEEdge Therapeutics, Inc.
02/05/201815h06GlobeNewswire Inc.Edge Shareholders: Bernstein Liebhard LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Edge Therapeut...NASDAQ:EDGEEdge Therapeutics, Inc.
25/04/201822h35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EDGEEdge Therapeutics, Inc.
25/04/201822h33Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EDGEEdge Therapeutics, Inc.
25/04/201819h33PR Newswire (US)Edge Shareholder Alert: Bernstein Liebhard LLP Announces That A Class Action Lawsuit Has Been Filed Against Edge Therapeutics...NASDAQ:EDGEEdge Therapeutics, Inc.
24/04/201821h27Business WireINVESTOR ALERT: Kirby McInerney LLP Announces a Securities Class Action on Behalf of Edge Therapeutics, Inc. InvestorsNASDAQ:EDGEEdge Therapeutics, Inc.
29/03/201815h34PR Newswire (US)Investor Alert: Kaplan Fox Announces Investigation Of Edge Therapeutics, Inc.NASDAQ:EDGEEdge Therapeutics, Inc.
28/03/201813h00GlobeNewswire Inc.Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid ...NASDAQ:EDGEEdge Therapeutics, Inc.
 Showing the most relevant articles for your search:NASDAQ:EDGE

Dernières Valeurs Consultées

BIT
UB7XW4
Unicredit Bank
BIT
F18070
Vontobel Financial Produ...
USOTC
SSCR
SMSA Crane Acquistion (CE)
NYSE
SQZ
SQZ Biotechnologies
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés